Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Apoptosis | 32 | 2024 | 9478 | 2.480 |
Why?
|
Apoptosis Regulatory Proteins | 10 | 2023 | 1138 | 1.600 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 14 | 2023 | 1404 | 1.550 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 3 | 2019 | 88 | 1.100 |
Why?
|
Mitochondria | 13 | 2024 | 3620 | 0.940 |
Why?
|
bcl-2-Associated X Protein | 6 | 2023 | 282 | 0.840 |
Why?
|
Cell Death | 6 | 2024 | 1676 | 0.750 |
Why?
|
bcl-X Protein | 9 | 2023 | 410 | 0.690 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 3 | 2023 | 71 | 0.630 |
Why?
|
Neoplasms | 12 | 2023 | 22125 | 0.620 |
Why?
|
Antineoplastic Agents | 9 | 2024 | 13630 | 0.600 |
Why?
|
Drug Resistance, Neoplasm | 9 | 2023 | 5300 | 0.520 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2017 | 430 | 0.480 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2016 | 987 | 0.460 |
Why?
|
Interleukins | 3 | 2016 | 782 | 0.420 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2017 | 686 | 0.420 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 5 | 2009 | 1405 | 0.410 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1850 | 0.360 |
Why?
|
Lymphoma, Primary Effusion | 1 | 2010 | 17 | 0.360 |
Why?
|
Drug Therapy | 1 | 2013 | 503 | 0.350 |
Why?
|
Interleukin-4 | 3 | 2009 | 1154 | 0.320 |
Why?
|
Genes, myc | 1 | 2009 | 390 | 0.310 |
Why?
|
Germinal Center | 3 | 2010 | 380 | 0.310 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2019 | 3591 | 0.310 |
Why?
|
Proto-Oncogene Proteins | 4 | 2023 | 4510 | 0.300 |
Why?
|
Cell Line, Tumor | 20 | 2024 | 16947 | 0.290 |
Why?
|
Boronic Acids | 1 | 2010 | 915 | 0.260 |
Why?
|
ras Proteins | 3 | 2017 | 1054 | 0.260 |
Why?
|
Nitrophenols | 2 | 2017 | 169 | 0.260 |
Why?
|
Vero Cells | 2 | 2021 | 482 | 0.260 |
Why?
|
Sulfonamides | 4 | 2022 | 1977 | 0.260 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2813 | 0.250 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9416 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2020 | 8529 | 0.250 |
Why?
|
Multiple Myeloma | 3 | 2022 | 5145 | 0.250 |
Why?
|
Ovarian Neoplasms | 6 | 2020 | 4853 | 0.250 |
Why?
|
HeLa Cells | 4 | 2019 | 3073 | 0.240 |
Why?
|
Pyrazines | 1 | 2010 | 1202 | 0.230 |
Why?
|
Animals | 26 | 2024 | 168083 | 0.230 |
Why?
|
MAP Kinase Signaling System | 3 | 2017 | 1480 | 0.230 |
Why?
|
Lymphoma, B-Cell | 3 | 2019 | 938 | 0.230 |
Why?
|
Caspases | 2 | 2023 | 878 | 0.210 |
Why?
|
Mice | 17 | 2024 | 81324 | 0.210 |
Why?
|
DNA Damage | 3 | 2024 | 2443 | 0.210 |
Why?
|
Mitochondrial Membranes | 1 | 2024 | 176 | 0.210 |
Why?
|
Galectin 3 | 1 | 2024 | 240 | 0.200 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2024 | 2914 | 0.200 |
Why?
|
Immunoglobulin Light Chains | 1 | 2022 | 286 | 0.190 |
Why?
|
Biphenyl Compounds | 2 | 2017 | 1007 | 0.190 |
Why?
|
Humans | 51 | 2024 | 761098 | 0.180 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10203 | 0.180 |
Why?
|
Signal Transduction | 12 | 2023 | 23415 | 0.170 |
Why?
|
Silanes | 1 | 2019 | 28 | 0.170 |
Why?
|
Nanoparticles | 2 | 2023 | 1959 | 0.170 |
Why?
|
Radioactivity | 1 | 2020 | 59 | 0.170 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2024 | 475 | 0.170 |
Why?
|
Immune Evasion | 1 | 2023 | 364 | 0.160 |
Why?
|
Alkylating Agents | 1 | 2019 | 133 | 0.160 |
Why?
|
Blood Proteins | 1 | 2024 | 1172 | 0.160 |
Why?
|
Silicon Dioxide | 1 | 2019 | 216 | 0.160 |
Why?
|
BRCA1 Protein | 2 | 2016 | 1149 | 0.150 |
Why?
|
Cell Survival | 5 | 2020 | 5776 | 0.150 |
Why?
|
Transaminases | 1 | 2018 | 199 | 0.150 |
Why?
|
Cells, Cultured | 3 | 2022 | 18926 | 0.150 |
Why?
|
Virus Internalization | 1 | 2021 | 496 | 0.140 |
Why?
|
STAT6 Transcription Factor | 2 | 2008 | 196 | 0.140 |
Why?
|
Amyloid | 1 | 2022 | 848 | 0.140 |
Why?
|
Protein Kinase Inhibitors | 5 | 2018 | 5662 | 0.140 |
Why?
|
Doxorubicin | 2 | 2016 | 2224 | 0.140 |
Why?
|
Membrane Proteins | 1 | 2013 | 7844 | 0.130 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2022 | 1488 | 0.130 |
Why?
|
Pyrazoles | 2 | 2017 | 2010 | 0.130 |
Why?
|
Heat-Shock Proteins | 1 | 2020 | 795 | 0.130 |
Why?
|
Pathology | 1 | 2019 | 269 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 636 | 0.130 |
Why?
|
Macrophages | 3 | 2019 | 5754 | 0.120 |
Why?
|
Uterine Neoplasms | 1 | 2024 | 1420 | 0.120 |
Why?
|
Dexamethasone | 1 | 2022 | 1945 | 0.120 |
Why?
|
Longevity | 1 | 2022 | 1064 | 0.120 |
Why?
|
Niacinamide | 1 | 2017 | 413 | 0.120 |
Why?
|
bcl-Associated Death Protein | 1 | 2014 | 102 | 0.120 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2023 | 5318 | 0.120 |
Why?
|
Mice, SCID | 3 | 2019 | 2621 | 0.110 |
Why?
|
Age Factors | 3 | 2021 | 18385 | 0.110 |
Why?
|
Topoisomerase Inhibitors | 1 | 2013 | 19 | 0.110 |
Why?
|
Disease | 1 | 2019 | 670 | 0.110 |
Why?
|
Fibroblasts | 1 | 2024 | 4137 | 0.110 |
Why?
|
Cyclophosphamide | 1 | 2019 | 2219 | 0.110 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2016 | 655 | 0.110 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 1301 | 0.110 |
Why?
|
Glutamic Acid | 1 | 2018 | 1173 | 0.100 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2015 | 237 | 0.100 |
Why?
|
MicroRNAs | 2 | 2023 | 3758 | 0.100 |
Why?
|
Cisplatin | 2 | 2019 | 1651 | 0.100 |
Why?
|
Organ Specificity | 1 | 2016 | 1963 | 0.100 |
Why?
|
Lung Neoplasms | 4 | 2023 | 13382 | 0.100 |
Why?
|
DNA Repair | 2 | 2018 | 2041 | 0.100 |
Why?
|
Janus Kinase 2 | 1 | 2014 | 559 | 0.090 |
Why?
|
Epigenomics | 1 | 2017 | 943 | 0.090 |
Why?
|
Proteomics | 2 | 2022 | 3836 | 0.090 |
Why?
|
Environmental Exposure | 2 | 2023 | 4479 | 0.090 |
Why?
|
Homeostasis | 2 | 2019 | 3318 | 0.090 |
Why?
|
E2F3 Transcription Factor | 1 | 2010 | 36 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1745 | 0.090 |
Why?
|
Genomics | 2 | 2024 | 5828 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 11732 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2017 | 9278 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2022 | 3550 | 0.080 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1348 | 0.080 |
Why?
|
Immunologic Factors | 2 | 2016 | 1589 | 0.080 |
Why?
|
Neoplasm Proteins | 3 | 2010 | 3594 | 0.080 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2010 | 234 | 0.080 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2016 | 1331 | 0.080 |
Why?
|
Immunotherapy | 2 | 2023 | 4642 | 0.080 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 22129 | 0.080 |
Why?
|
Myeloproliferative Disorders | 1 | 2014 | 609 | 0.080 |
Why?
|
Herpesvirus 8, Human | 1 | 2010 | 255 | 0.080 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2008 | 96 | 0.080 |
Why?
|
Unfolded Protein Response | 1 | 2010 | 234 | 0.080 |
Why?
|
Virion | 1 | 2010 | 422 | 0.080 |
Why?
|
Diphenylamine | 2 | 2018 | 49 | 0.070 |
Why?
|
Doxycycline | 1 | 2009 | 344 | 0.070 |
Why?
|
B-Lymphocyte Subsets | 1 | 2008 | 238 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 2022 | 3163 | 0.070 |
Why?
|
Transcriptional Activation | 1 | 2013 | 1751 | 0.070 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2016 | 2426 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2014 | 2864 | 0.070 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 694 | 0.070 |
Why?
|
Receptors, Interleukin-21 | 2 | 2016 | 32 | 0.070 |
Why?
|
Mice, Nude | 3 | 2018 | 3604 | 0.070 |
Why?
|
Child | 3 | 2023 | 80134 | 0.070 |
Why?
|
Air Pollution | 1 | 2020 | 2351 | 0.070 |
Why?
|
RNA, Neoplasm | 1 | 2008 | 748 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2022 | 4251 | 0.060 |
Why?
|
Air Pollutants | 1 | 2020 | 2889 | 0.060 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2009 | 677 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2010 | 1837 | 0.060 |
Why?
|
Cell Movement | 2 | 2024 | 5195 | 0.060 |
Why?
|
Hematopoietic Stem Cells | 1 | 2018 | 3388 | 0.060 |
Why?
|
Mutation | 5 | 2018 | 30006 | 0.060 |
Why?
|
HCT116 Cells | 2 | 2016 | 404 | 0.060 |
Why?
|
Aging | 1 | 2024 | 8701 | 0.060 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 1640 | 0.060 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2007 | 456 | 0.060 |
Why?
|
Medical Oncology | 1 | 2016 | 2316 | 0.060 |
Why?
|
Pyrimidines | 1 | 2016 | 3026 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3790 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2017 | 2331 | 0.050 |
Why?
|
Glioma | 1 | 2018 | 3452 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15845 | 0.050 |
Why?
|
DNA Replication | 1 | 2010 | 1415 | 0.050 |
Why?
|
Down-Regulation | 1 | 2010 | 2915 | 0.050 |
Why?
|
Tumor Necrosis Factors | 1 | 2023 | 109 | 0.050 |
Why?
|
Hematologic Neoplasms | 1 | 2014 | 1895 | 0.050 |
Why?
|
Lung | 1 | 2021 | 9979 | 0.050 |
Why?
|
Female | 14 | 2024 | 392458 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2023 | 188 | 0.050 |
Why?
|
Cell Cycle | 1 | 2010 | 2926 | 0.050 |
Why?
|
Benzamides | 2 | 2018 | 1370 | 0.050 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6123 | 0.050 |
Why?
|
NF-kappa B | 1 | 2010 | 2475 | 0.050 |
Why?
|
Janus Kinases | 1 | 2023 | 248 | 0.050 |
Why?
|
Lymphoma | 1 | 2010 | 1898 | 0.050 |
Why?
|
Spheroids, Cellular | 1 | 2023 | 329 | 0.050 |
Why?
|
Galectins | 1 | 2024 | 296 | 0.050 |
Why?
|
RNA, Small Interfering | 2 | 2022 | 3409 | 0.050 |
Why?
|
Child, Preschool | 1 | 2023 | 42217 | 0.040 |
Why?
|
Up-Regulation | 1 | 2009 | 4111 | 0.040 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2023 | 543 | 0.040 |
Why?
|
Phase Transition | 1 | 2020 | 71 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6507 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2020 | 11505 | 0.040 |
Why?
|
Infant | 1 | 2021 | 36164 | 0.040 |
Why?
|
Heat-Shock Response | 1 | 2020 | 179 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11118 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2009 | 5478 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2019 | 9185 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2007 | 2881 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2024 | 974 | 0.040 |
Why?
|
Survival Analysis | 1 | 2010 | 10083 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1131 | 0.040 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2018 | 294 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2016 | 64670 | 0.040 |
Why?
|
Pregnancy Proteins | 1 | 2018 | 222 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2020 | 7574 | 0.040 |
Why?
|
Cities | 1 | 2020 | 541 | 0.040 |
Why?
|
HMGA2 Protein | 1 | 2017 | 101 | 0.040 |
Why?
|
Models, Biological | 1 | 2013 | 9455 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10755 | 0.040 |
Why?
|
Indolizines | 1 | 2016 | 30 | 0.030 |
Why?
|
Cyclic N-Oxides | 1 | 2016 | 72 | 0.030 |
Why?
|
Glutarates | 1 | 2018 | 243 | 0.030 |
Why?
|
Pyridinium Compounds | 1 | 2016 | 81 | 0.030 |
Why?
|
Surface Properties | 1 | 2019 | 1162 | 0.030 |
Why?
|
Organoids | 1 | 2023 | 744 | 0.030 |
Why?
|
Cell-Free System | 1 | 2016 | 336 | 0.030 |
Why?
|
Histiocytic Sarcoma | 1 | 2016 | 40 | 0.030 |
Why?
|
Piperazines | 2 | 2017 | 2522 | 0.030 |
Why?
|
Phosphorylation | 3 | 2014 | 8303 | 0.030 |
Why?
|
Cell Transdifferentiation | 1 | 2016 | 186 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2017 | 584 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2023 | 1966 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1822 | 0.030 |
Why?
|
Random Allocation | 1 | 2019 | 2393 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3155 | 0.030 |
Why?
|
Biomimetic Materials | 1 | 2016 | 172 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15513 | 0.030 |
Why?
|
Cell Membrane Permeability | 1 | 2016 | 573 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1812 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2020 | 20981 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 799 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2024 | 10421 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2018 | 1073 | 0.030 |
Why?
|
Benzoquinones | 1 | 2013 | 198 | 0.030 |
Why?
|
Rad51 Recombinase | 1 | 2013 | 189 | 0.030 |
Why?
|
Male | 5 | 2021 | 360675 | 0.030 |
Why?
|
Mutation, Missense | 2 | 2014 | 2567 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2016 | 1351 | 0.030 |
Why?
|
Tumor Burden | 1 | 2018 | 1892 | 0.030 |
Why?
|
Plasmids | 1 | 2017 | 2261 | 0.030 |
Why?
|
Immunomodulation | 1 | 2016 | 549 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 2227 | 0.030 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 937 | 0.020 |
Why?
|
Platinum | 1 | 2013 | 220 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2017 | 1240 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1662 | 0.020 |
Why?
|
Paclitaxel | 1 | 2019 | 1730 | 0.020 |
Why?
|
Lactams, Macrocyclic | 1 | 2013 | 318 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2016 | 5103 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2013 | 426 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2019 | 2138 | 0.020 |
Why?
|
Adult | 3 | 2022 | 221083 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2016 | 871 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2015 | 872 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 2 | 2013 | 2802 | 0.020 |
Why?
|
Immune System | 1 | 2016 | 792 | 0.020 |
Why?
|
Middle Aged | 3 | 2021 | 220835 | 0.020 |
Why?
|
Peptides | 1 | 2023 | 4353 | 0.020 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2013 | 422 | 0.020 |
Why?
|
Calcium | 1 | 2023 | 5720 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2011 | 295 | 0.020 |
Why?
|
Adenine | 1 | 2016 | 986 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2189 | 0.020 |
Why?
|
Aged | 2 | 2021 | 169266 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 1737 | 0.020 |
Why?
|
Contrast Media | 1 | 2023 | 5311 | 0.020 |
Why?
|
Cell Membrane | 1 | 2019 | 3665 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2016 | 58946 | 0.020 |
Why?
|
Permeability | 1 | 2011 | 721 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2018 | 14393 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2911 | 0.020 |
Why?
|
Indoles | 1 | 2017 | 1830 | 0.020 |
Why?
|
TYK2 Kinase | 1 | 2008 | 38 | 0.020 |
Why?
|
BRCA2 Protein | 1 | 2013 | 797 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2896 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2452 | 0.020 |
Why?
|
Metalloproteins | 1 | 2008 | 97 | 0.020 |
Why?
|
Inflammation | 2 | 2024 | 10758 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2019 | 3114 | 0.020 |
Why?
|
Particulate Matter | 1 | 2020 | 2597 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2528 | 0.020 |
Why?
|
STAT5 Transcription Factor | 1 | 2008 | 266 | 0.020 |
Why?
|
Staurosporine | 1 | 2008 | 241 | 0.020 |
Why?
|
Piperidines | 1 | 2016 | 1656 | 0.020 |
Why?
|
Cell Line | 2 | 2015 | 15542 | 0.020 |
Why?
|
Interferon Regulatory Factors | 1 | 2008 | 261 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 39953 | 0.020 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2010 | 569 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2007 | 51 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3779 | 0.020 |
Why?
|
Protein Binding | 2 | 2010 | 9300 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2015 | 2194 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2455 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2392 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2010 | 1129 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13404 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2007 | 702 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 1168 | 0.010 |
Why?
|
Prognosis | 1 | 2024 | 29672 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2015 | 4372 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 1549 | 0.010 |
Why?
|
Immunologic Memory | 1 | 2008 | 1361 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 5993 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2011 | 6817 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8000 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2870 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5667 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16572 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2013 | 5781 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 2892 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 3700 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2008 | 2974 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 36418 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2011 | 3609 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 12743 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2008 | 9566 | 0.010 |
Why?
|